Thomas L. Goldsworthy
- Cancer Research top 1%
- Molecular Biology top 5%
- Health, Toxicology and Mutagenesis top 1%
- Oncology top 5%
- Pharmacology top 0.5%
- Co-authors
- Henry C. PitotByron E. ButterworthRobert R. MaronpotHarold A. CampbellDouglas C. WolfJames A. PoppJeffrey I. EverittRonny Fransson-Steen
- Topics
- Carcinogens and Genotoxicity Assessment (29 papers)Drug Transport and Resistance Mechanisms (13 papers)Pharmacogenetics and Drug Metabolism (10 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Thomas L. Goldsworthy
87 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 1.7k
- Molecular Biology 1.6k
- Health, Toxicology and Mutagenesis 934
- Oncology 696
- Pharmacology 606
Countries citing papers authored by Thomas L. Goldsworthy
This map shows the geographic impact of Thomas L. Goldsworthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas L. Goldsworthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas L. Goldsworthy more than expected).
Fields of papers citing papers by Thomas L. Goldsworthy
This network shows the impact of papers produced by Thomas L. Goldsworthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas L. Goldsworthy. The network helps show where Thomas L. Goldsworthy may publish in the future.
Co-authorship network of co-authors of Thomas L. Goldsworthy
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas L. Goldsworthy. A scholar is included among the top collaborators of Thomas L. Goldsworthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas L. Goldsworthy. Thomas L. Goldsworthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 8 | |
| 3 | 45 | |
| 4 | 3 | |
| 5 | 6 | |
| 6 | 15 | |
| 7 | 36 | |
| 8 | 3 | |
| 9 | 26 | |
| 10 | 22 | |
| 11 | 60 | |
| 12 | 89 | |
| 13 | 61 | |
| 14 | 48 | |
| 15 | 62 | |
| 16 | 59 | |
| 17 | 29 | |
| 18 | 37 | |
| 19 | 72 | |
| 20 | 194 |
About Thomas L. Goldsworthy
Thomas L. Goldsworthy is a scholar working on Cancer Research, Pharmacology and Hepatology, having authored 87 papers that have together received 4.1k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (29 papers), Drug Transport and Resistance Mechanisms (13 papers) and Pharmacogenetics and Drug Metabolism (10 papers). The work is most often cited by research in Cancer Research (1.7k citations), Pharmacology (606 citations) and Health, Toxicology and Mutagenesis (934 citations). Thomas L. Goldsworthy has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Henry C. Pitot, Byron E. Butterworth, Robert R. Maronpot, Harold A. Campbell, Douglas C. Wolf, James A. Popp, Jeffrey I. Everitt, Ronny Fransson-Steen, Alan Poland and Sandra R. Eldridge. Their work appears in journals such as Science, Cancer Research and Environmental Health Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.